These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37236776)

  • 1. Evaluation of drug interaction between cyclosporine and lercanidipine: a descriptive study.
    Tecen-Yucel K; Bayraktar-Ekincioglu A; Yıldırım T; Demirkan K; Erdem Y
    Eur J Hosp Pharm; 2024 Oct; 31(6):560-563. PubMed ID: 37236776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children.
    Bernard E; Goutelle S; Bertrand Y; Bleyzac N
    Ann Pharmacother; 2014 Dec; 48(12):1580-4. PubMed ID: 25280976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients.
    Tecen-Yucel K; Bayraktar-Ekincioglu A; Yildirim T; Yilmaz SR; Demirkan K; Erdem Y
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1291-1296. PubMed ID: 32996393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
    Sperschneider H; Wagner C; Korn A; Christians U
    Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.
    Park JW; Siekmeier R; Lattke P; Merz M; Mix C; Schüler S; Jaross W
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):351-61. PubMed ID: 11907637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction between oral cyclosporin and mibefradil in stabilized post-renal-transplant patients.
    Spoendlin M; Peters J; Welker H; Bock A; Thiel G
    Nephrol Dial Transplant; 1998 Jul; 13(7):1787-91. PubMed ID: 9681729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in lercanidipine systemic exposure when administered according to labelling: in fasting state and 15 minutes before food intake.
    Álvarez C; Gómez E; Simón M; Govantes C; Guerra P; Frías J; García-Arieta A
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1043-7. PubMed ID: 22294059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.
    Hanauer Schaab E; Lanchote VL; Balthazar Nardotto GH; Marques Pereira MP; Dantas M; Paiva CE; Barbosa Coelho E
    J Clin Pharmacol; 2020 Jan; 60(1):75-85. PubMed ID: 31353479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG
    Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y; Zhang XD; Wang Y
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients.
    Romero AJ; Le Pogamp P; Nilsson LG; Wood N
    Clin Pharmacol Ther; 2002 Apr; 71(4):226-34. PubMed ID: 11956505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
    Lam H; Jeffery J; Sitar DS; Aoki FY
    Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring Data.
    Albitar O; Ballouze R; Harun SN; Mohamed Noor DA; Sheikh Ghadzi SM
    J Clin Pharmacol; 2020 Nov; 60(11):1474-1482. PubMed ID: 32557653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of cyclosporine nephrotoxicity after conversion from Sandimmune to Neoral.
    Sijpkens YW; Mallat MJ; Siegert CE; Zwinderman AH; Westendorp RG; de Fijter JW; van Es LA; Paul LC
    Clin Nephrol; 2001 Feb; 55(2):149-55. PubMed ID: 11269679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients.
    Rostami Z; Einollahi B; Morshedi J; Teimoori M
    Iran J Kidney Dis; 2012 Sep; 6(5):373-9. PubMed ID: 22976264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of genetic polymorphisms of CYP3A5 and MDR1 on cyclosporine concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.
    Wang Y; Wang C; Li J; Wang X; Zhu G; Chen X; Bi H; Huang M
    Eur J Clin Pharmacol; 2009 Mar; 65(3):239-47. PubMed ID: 18936931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between cyclosporine A and verapamil, felodipine, and isradipine.
    Yildiz A; Sever MS; Türkmen A; Ecder T; Türk S; Akkaya V; Ark E
    Nephron; 1999 Jan; 81(1):117-8. PubMed ID: 9884436
    [No Abstract]   [Full Text] [Related]  

  • 20. Lercanidipine : a review of its efficacy in the management of hypertension.
    Bang LM; Chapman TM; Goa KL
    Drugs; 2003; 63(22):2449-72. PubMed ID: 14609358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.